Safety and efficacy of autologous tumor lysate particle-loaded dendritic cell vaccination in combination with systemic therapies in patients with recurrent and metastatic melanoma

MLA

Guy T. Clifton, et al. “Safety and Efficacy of Autologous Tumor Lysate Particle-Loaded Dendritic Cell Vaccination in Combination with Systemic Therapies in Patients with Recurrent and Metastatic Melanoma.” Melanoma Research, vol. 31, no. 4, July 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3285e61714d7b96b3908fe816d7c3944&authtype=sso&custid=ns315887.

APA

Guy T. Clifton, Jeffrey J. Sussman, Timothy J. Vreeland, John R. Hyngstrom, Diane F. Hale, Amanda JoEllen Sloan, Adam C. Berger, Phillip M. Kemp Bohan, Thomas E. Wagner, Patrick M. McCarthy, George E. Peoples, Hyohyun Park, Mark B. Faries, James W. Jakub, Robert C. Chick, Alexandra M Adams, Montaser Shaheen, Anne E O’Shea, & Annelies T. Hickerson. (2021). Safety and efficacy of autologous tumor lysate particle-loaded dendritic cell vaccination in combination with systemic therapies in patients with recurrent and metastatic melanoma. Melanoma Research, 31(4).

Chicago

Guy T. Clifton, Jeffrey J. Sussman, Timothy J. Vreeland, John R. Hyngstrom, Diane F. Hale, Amanda JoEllen Sloan, Adam C. Berger, et al. 2021. “Safety and Efficacy of Autologous Tumor Lysate Particle-Loaded Dendritic Cell Vaccination in Combination with Systemic Therapies in Patients with Recurrent and Metastatic Melanoma.” Melanoma Research 31 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3285e61714d7b96b3908fe816d7c3944&authtype=sso&custid=ns315887.